EGFR and melanoma: We further investigated the relevance of the phosphorylation signature identified in the context of MET addiction in three additional models of oncogene addiction that have acquired widespread attention in clinical practice: the RTKs EGFR and ALK in NSCLC and the serine/threonine kinase BRAF in melanoma [54–56].